{"entity":{"id":"cellsight-technologies","kind":"company","name":"CellSight Technologies","aka":["CellSight Technologies, Inc."],"tldr":"CellSight Technologies is a US-based imaging company that leads 2 cancer trials in OnCo, testing the activated T-cell PET tracer [18F]F-AraG (VisAcT) in non-small-cell lung cancer.","summary":"CellSight Technologies develops molecular imaging agents that originated in Sanjiv Gambhir's laboratory at Stanford University. Its lead agent VisAcT ([18F]F-AraG) is a PET tracer that accumulates in activated T cells, intended to help select patients for immunotherapy, assess early response and detect immune-related side effects. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo: NCT06107374 (phase 2, Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG) and NCT06084806 (phase 2, Test-retest Evaluation of [18F]F-AraG PET). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://www.cellsighttech.com"},{"label":"ClinicalTrials.gov: trials led by CellSight Technologies","url":"https://clinicaltrials.gov/search?lead=CellSight%20Technologies%2C%20Inc."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06107374","nct06084806"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo orphan-trial linking round (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-17"},"hq":"San Francisco, California","country":"US","companyType":"imaging","website":"https://www.cellsighttech.com","stage":"startup","investors":[],"funding":[]},"route":"/companies/cellsight-technologies/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"trial":[{"id":"nct06107374","kind":"trial","name":"Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG","route":"/trials/nct06107374/"},{"id":"nct06084806","kind":"trial","name":"Test-retest Evaluation of [18F]F-AraG PET","route":"/trials/nct06084806/"}]}}